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Abstract
Background: Epidemiological studies showed that physical exercise, specifically moderate lifelong
training, is protective against cardiovascular morbidity and mortality. Most experimental work has
focused into the effects and molecular mechanisms underlying intense, rather than mild exercise,
by exploring the acute effect of training. Our study aims at investigating the cardioprotective effect
of mild chronic exercise training and the gene expression profile changes at 48 hrs after the
exercise cessation. Rats were trained at mild intensity on a treadmill: 25 m/min, 10%incline, 1 h/
day, 3 days/week, 10 weeks; about 60% of the maximum aerobic power. By Affymetrix technology,
we investigated the gene expression profile induced by exercise training in the left ventricle (LV)
of trained (n = 10) and control (n = 10) rats. Cardioprotection was investigated by ischemia/
reperfusion experiments (n = 10 trained vs. n = 10 control rats).
Results: Mild exercise did not induce cardiac hypertrophy and was cardioprotective as
demonstrated by the decreased infarct size (p = 0.02) after ischemia/reperfusion experiments in
trained with respect to control rats. Ten genes and 2 gene sets (two pathways) resulted altered in
LV of exercised animals with respect to controls. We validated by real-time PCR the increased
expression of four genes: similar to C11orf17 protein (RGD1306959), caveolin 3, enolase 3, and
hypoxia inducible factor 1 alpha. Moreover, caveolin 3 protein levels were higher in exercised than
control rats by immunohistochemistry and Western Blot analysis. Interestingly, the predicted gene
similar to C11orf17 protein (RGD1306959) was significantly increased by exercise. This gene has
a high homology with the human C11orf17 (alias: protein kinase-A interacting protein 1 or breast
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exercise training.
Conclusion: Our data indicated that few, but significant, genes characterize the gene expression
profile of the rat LV, when examined 48 hrs since the last training section and that mild exercise
training determines cardioprotection without the induction of hypertrophy.
Background
A large number of epidemiologic studies have empha-
sized the relationship between increased physical activity
during leisure time to both the reduced progression of
atherosclerosis [1] and risk of cardiovascular disease [2,3].
Exercise has been related to reduced post-ischemia infarct
size, in a manner dependent on the regularity and inten-
sity of exercise [4-8]. Recent studies have clearly shown
that training at moderate to high intensity increases myo-
cardial tolerance to ischemia/reperfusion (I/R) [9],
improves cardiac performance and cell defence capacity
against stress [10,11]. It has been suggested that the mech-
anisms underlying training-induced cardioprotection
resemble those evidenced by ischemic preconditioning,
e.g. the phenomenon whereby short ischemic episodes
given before a major ischemic insult lead to endogenous
cardioprotection [12]. Ischemic preconditioning results in
cardioprotection within two time windows: a first win-
dow within 2–3 hours from the injury and a second win-
dow 24–72 hours later [13].
Recently, mild chronic exercise training (14 weeks,
increasing in intensity to 55% of the maximum aerobic
power, VO2max), which resembles the procedure recom-
mended for middle-aged human beings (Recommenda-
tions of the American College of Sport Medicine,
http:www.acsm.org//AM/Template.cfm?Sec
tion=Home_Page), was demonstrated to protect the heart
against I/R [14] in a similar way to more intense training
programs [9-11]. The cellular and molecular mechanisms
by which exercise training, and in particular mild exercise
training, exerts its effects on the heart are partially under-
stood due, at least in part, to the complex and pleiotropic
nature of the exercise stimulus. A possible way to
approach this fundamental issue is to use microarray tech-
nology to identify differentially expressed transcripts. In
fact, whole genome technologies may facilitate the identi-
fication of genes or gene sets/pathways that have not so far
been associated with exercise training. Reports based on
the microarray approach are beginning to emerge con-
cerning the evaluation of responses to the physical exer-
cise of leukocytes [15], skeletal muscle [16], and left
ventricle (LV) [9,17,18].
In order to get a greater insight into the molecular mech-
anisms underlying the beneficial effects of mild physical
exercise, we investigated the cardioprotective effect and
evaluated gene expression changes induced by mild
chronic exercise training in the LV of the rat. We focused
into the gene expression changes at 48 hours after the last
exercise session for the purpose of: a) characterizing the
"permanent" instead of acute gene expression profile in
response to physical exercise, and b) comparing and
extending previously obtained data by including larger
gene sets and population [14].
Methods
Animals and experimental design
Animal handling, training protocol and mode of sacrifice
were approved by the Ethical Committee on the Use of
Laboratory Animals of the Health Authority of Milan
(Italy) according to the 86/609/CEE guidelines. Training
was carried out according to the American Physiological
Society guidelines for exercising rodents on treadmills
(American Physiological Society, 2006 http://www.the-
aps.org/pa/action/exercise/book.pdf). The investigation
conforms to the Guide for the Care and Use of Laboratory
Animals published by the National Institutes of Health
[19]. We used 40 male Sprague-Dawley-CD rats (8 weeks
old, 360 ± 15 g body weight at the beginning of the study),
randomly divided into two groups: exercise-trained (TRA)
animals and sedentary controls (CTR). During the experi-
mental period, all animals had free access to water and a
conventional laboratory diet (Standard diet n.48, Labora-
torio Dr Piccioni, Milan, Italy) until sacrifice. Room tem-
perature was kept at 21 ± 2°C and 12 h of light was
automatically alternated to 12 h of darkness. Rats were
periodically examined by a veterinarian. Food consump-
tion and body weight were evaluated three times a week.
Their internal organs, as examined by a pathologist on the
day of sacrifice, appeared to be normal and disease free.
Exercise training
After one week of acclimatization, 20 animals were ran-
domly chosen to run on a treadmill (Medical Instruments,
U.S.A.) at 10%-grade. The training protocol required two
weeks of gradually increasing effort and time of exercise
up to 25 m/min for 1 h/day, 3 days/week, for a total of 10
weeks. According to previous studies [20,21], the training
exercise intensity used in the present work corresponded
to ~60% of the maximum aerobic power VO2max [20].
Control animals (n = 20) were placed on a non-moving
treadmill during the training sections.
Forty eight hours after the last run, 10 TRA rats and 10
CTR rats were anesthetized (100 mg/kg ip heparinizedPage 2 of 13
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then heart and soleus muscles were removed. Blood from
the heart was accurately squeezed out and soleus muscles
were blotted and freed of connective tissue before they
were weighed.
Left ventricles were immediately frozen in liquid nitrogen
and stored at -80°C until RNA and protein extraction for
microarray, real time (RT)-PCR, western blot analyses and
immunohistochemistry assay were performed.
Total RNA extraction and gene expression profiling by 
Affymetrix GeneChip analysis
Frozen cardiac tissue was reduced to powder by means of
a sterilized ceramic mortar and pestle. RNA was isolated
by using TRIZOL™ (Invitrogen, Milan, Italy), as suggested
by the manufacturer. The presence of RNA degradation
was assessed by evaluation of 28S and 18S band sharpness
after denaturing electrophoresis. Quantification and
purity of RNA samples was performed by 260 and 280
spectrophotometer analysis; a 260/280 absorbance ratio
ranging between 1.8 and 2.1 being acceptable. We deter-
mined, by microarray technology, the contemporary
expression of 31,000 probe sets (each set of 25-mer oligo-
nucleotides on the GeneChip recognized a transcript) rep-
resenting 30,000 transcripts and variants from over
28,000 well-substantiated rat genes. To this purpose we
used the Affymetrix GeneChip technology and GeneChip
Rat Genome 230 v2.0 Array (Affymetrix, Santa Clara, CA).
Standard protocols for chip hybridizations (available at
http://www.affymetrix.com), One-Cycle Target Labeling
kit, and Control Reagents kit were used (Affymetrix, Santa
Clara, CA). Briefly, double-stranded cDNA was synthe-
sized by reverse transcriptase reaction from total RNA
extracted from the LV of all animals (CTR and TRA).
cDNA was then used to obtain biotin-labeled cRNA by in
vitro transcription reaction. After the clean-up procedure
of biotinylated cRNA, the cRNA was fragmented before
hybridization. After an over-night hybridization, Gene-
Chips were washed and stained with streptoavidin-phyco-
erythrin conjugate and biotinylated anti-streptavidin
antibody. RNA from individual animals was hybridized to
each chip. After the scanning procedure, data files were
checked for quality parameters (such as scale factor, back-
ground noise, corner and central fluorescent intensities,
GAPDH and Actin 3'/5' ratio values and percentage of
expressed probe sets). Microarray data analysis was per-
formed according to Affymetrix suggestions (GeneChip
Expression Analysis: data analysis fundamentals in http://
www.affymetrix.com) and was based on our previous
experience in microarray technology [22,23].
Data Extraction and Statistical Analysis
Data reported in this publication have been deposited in
the National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo) and are accessible through
GEO Series accession number GSE7640 (to allow review
of GSE7640 before the manuscript acceptance:
http:www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token=jpelt soyskkoklw&acc=GSE7640).
Image and expression data files were generated with
Affymetrix MAS 5.0. The average percentage of probe sets
with "present calls" (qualitative detection of transcripts)
was 48.1%, indicating that the array hybridizations were
of good quality. Low level and statistical analysis was
done using R 2.3. Microarray data were first processed in
R environment http://www.r-project.org by Affymetrix
package to identify present/absent probe set, and then
subjected to a normalization step. We normalized data
according to the MicroArray Suite (MAS) method: back-
ground correction with MAS method, normalization at a
probe level with constant method (a global adjustment by
a constant value to equalize the chip-wide mean signal
intensity between chips) [24], and summary of the probe
set intensities with the method of averaged differences
http://www.affymetrix.com, http://www.bioconduc
tor.org.
In order to identify differentially expressed genes, at statis-
tically significant level, in LV of TRA and CTR rats, we
applied a t-statistic variant approach. We used the signifi-
cance analysis of microarrays (SAM) method [25], in
which the t-statistic has a constant value added to the
standard deviation. We performed SAM analysis with
Siggenes package http://www.bioconductor.org[26]. The
minimization of the FDR allowed us to identify 12 differ-
entially expressed probe sets with a delta equal to 0.7 and
FDR 19%. All the analysis was written in the freely availa-
ble statistical language R.
In order to increase the information content of our data-
set, Gene Set Analysis (GSA) was applied using the GSA R
package http://www-stat.stanford.edu/~tibs/GSA/. GSA is
a computational method that determines whether an a
priori defined set of genes shows statistically significant
concordant differences between two biological states. This
method allowed us to investigate whether genes involved
in the same biological functions or pathways resulted co-
regulated, even if they did not result differentially
expressed at statistically significant levels by SAM method.
GSA is a modification of the Gene Set Enrichment Analy-
sis (GSEA) [27] that makes use of the "maxmean" statistic
instead of Kolmogorov-Smirnov statistic to score gene
sets. The analysis was performed on 459 a priori defined
gene sets (a gene set is defines by genes involved in the
same biological process, molecular function, cellular
component, or pathway) that were downloaded at the
Molecular Signatures Database site http://
www.broad.mit.edu/gsea/msigdb/index.jsp.Page 3 of 13
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Expression patterns of 4 genes [similar to C11orf17 pro-
tein (RGD1306959), caveolin 3 (Cav3), enolase 3 (Eno3)
and hypoxia inducible factor 1 (Hif-1)] were validated by
RT-PCR. Reverse transcription was performed making use
of Omniscript Reverse Transcription Kit (Qiagen, Hilden,
Germany). The primer sequences, the size of the amplifi-
cation products and the mean efficiency of the amplifica-
tion reactions are given in Additional File 1. Primers were
chosen by using the AMPLIFY free software; whenever
possible, primers were designed to span an exon-exon
junctions and were localized at the 3' end; for similar to
C11orf17 protein (RGD1306959) gene, the primers were
designed away from the 3' end because of the similarity of
its 3' sequence with that of other genes, as examined by
nBLAST analysis. Primers were obtained from PROLIGO
(Proligo, France SAS). The presence of unspecific products
was ruled out after analyzing the melting curve of the
amplicons. RT-PCR was performed in an ABI PRISM 5700
real-time thermal cycler using the SYBR Green kit (Qia-
gen). The reactions were performed in quadruplicate; the
final volume (25 μL) contained QuantiTect SYBR Green
PCR Master Mix, primers (0.3 μM each), and 10 ng of
cDNA. Inter-plate differences were less than 3.5% and
intra-plate differences were even lower. Standardization
curves were run in the range from 2.5 to 40 ng cDNA input
and were highly linear (Pearson correlation coefficient r >
0.997). PCR efficiencies were calculated from the slopes
obtained by ABI PRISM software; the efficiency (E) of each
PCR cycle in the exponential phase was calculated accord-
ing to the equation E = 10(-1/slope). For each gene, differ-
ences in the PCR efficiency of the 20 samples were less
than 5% and were not considered in the final calculations.
The relative gene quantification method developed by
Pfaffl [28] was applied, one of the samples having been
randomly chosen as a control. Expression of target genes
was calculated based on E and the crossing point devia-
tion of unknown samples versus a control and expressed
in comparison to the housekeeping gene. Values are then
expressed in arbitrary units, setting to 100 the amount of
RPL13a in 10 ng cDNA input.
Western Blot
LV cryomicrotome slices were lysed in RIPA buffer. Lysates
(30 μg) were run in SDS-PAGE minigels (12% acrylamide-
bis acrylamide, 30:1) and blotted into nitrocellulose
membranes by standard procedures. Rabbit anti-rat mon-
oclonal antibodies for caveolin-3 immunodetection were
obtained from BD Transduction Lab, Lexington, while
mouse anti-rat beta-actin polyclonal antibodies were
obtained from Sigma and were used at 1:2000 and 1:200
dilution, respectively. HRP-conjugated secondary anti-
bodies (1:5000) were purchased from Sigma. HRP chemi-
luminescent reaction was developed using Super Signal
West Dura Extended Duration (Pierce, Rockford, IL) and
used to expose Kodak Biomax Light film. The spots were
quantified by means of BioRad GelDoc 2000 and results
were expressed as caveolin-3 to beta-actin ratio.
Immunohistochemistry
For the quantification of caveolin-3, LV sections (5 μm-
thick) were obtained from the frozen specimens with ran-
dom orientation; they were fixed in cold 4% paraformal-
dehyde, marked with mouse anti-rat monoclonal
antibodies for caveolin-3 (diluted 1:100, BD Transduc-
tion Lab, Lexington), followed by incubation with Super
Sensitive Polymer-HRP IHC Biogenex, USA and develop-
ment of the chromogen reaction with 3,3'diaminobenzi-
dine (DAB). The slides were assigned conventional
numbers, so that the operator was blind to the training
status of the rat. Under the light microscope, at 250× mag-
nification, 30 non-overlapping fields were randomly
selected for each section, avoiding areas with holes, folds,
staining defects or large vessels. Images were acquired by
a 3 CCD (charge-coupled device) color video camera (KY
F55B, JVC Italia, Milan, Italy), and examined with an
image processing software (Image-Pro Plus, Media Cyber-
netics, Silver Spring, MD, USA). A specific function of the
software allows the operator to interactively define the
threshold for the automatic measurement of the struc-
tures intensely brown-stained, excluding any other struc-
ture less intensely stained in brown (background staining)
or stained with other colors. By means of this system, for
each microscopic field evaluated, the area stained with
anti-caveolin-3 antibody, identified by an intense brown
staining, was measured and expressed as a percentage of
the total area. The total surface thus evaluated per condi-
tion was 2.7 mm2. Some slides were counterstained with
hematoxylin, in order to appreciate the tissue morphol-
ogy.
Immunofluorescence labeling
In order to identify caveolin-3 (+) cells, heart cryo-sec-
tions were double labeled with a) mouse anti-rat mono-
clonal antibodies for caveolin-3 (diluted 1:100, BD
Transduction Lab, Lexington), plus FITC-conjugated rab-
bit anti-mouse polyclonal antibody (diluted 1:250,
DAKO, Germany) and b) goat anti-rat polyclonal anti-
body for myosin heavy chain (diluted 1:100, Santa Cruz
Biotechnology Inc., Santa Cruz, Ca) plus TRITC-conju-
gated bovine anti-goat polyclonal antibody (diluted
1:100, Santa Cruz Biotechnology Inc., Santa Cruz, Ca).
Slides were mounted with Pro Long Antifade Reagent with
DAPI (Molecular Probes, Canada).
Ischemia reperfusion experiments
Forty eight hours after the last training session, 10 exer-
cised rats and 10 control rats were used for I/R experi-
ments as previously described [14]. Briefly, rats were
anesthetized by intra-peritoneal injection of sodiumPage 4 of 13
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constant at 37°C by use of a heating platform controlled
by a thermostat. Animals were intubated through a trache-
otomy and ventilated mechanically (tidal volume 3 mL;
ventilation rate 50 strokes/min). A left thoracotomy was
performed between the 3rd and 4th rib to allow access to
the heart. A silk suture (6/0) was passed around the left
coronary artery and a small polyethylene catheter was
used to form a snare. All rats were allowed 10 min after
the completion of the surgical preparation to reach a
steady state before beginning the protocol. The left coro-
nary artery branch was occluded by pulling the snare and
the occluded position was maintained for 30 min by
means of a haemostatic clamp. Hearts were reperfused for
90 min by releasing the snare, and then they were
removed, cannulated via the aorta and perfused with 15–
20 mL saline at room temperature to wash out the blood.
The left coronary branch was re-occluded and a saturated
Evans blue solution (2 mL) was injected through the aorta
and upstream the occlusion to mark the ischemic zone as
the area without the dye. Hearts were then briefly frozen
in liquid nitrogen and stored at -20°C.
To measure the infarcted area, hearts were cut into five or
six transverse slices (1 mm thick). Slices were incubated in
triphenyltetrazolium chloride in sodium phosphate
buffer at 37°C for 20 min to stain viable cells in the risk
zone. Finally, the slices were immersed in 10% formalin
for 4 days to enhance contrast between stained and
unstained areas. Stained and unstained areas were calcu-
lated from computerized images of the slices using NIH
Image software (NIH AutoExtractor 1.51; National Insti-
tutes of Health) and averaged for all the slices.
Statistical Analysis
The data were analyzed by using SPSS (version 11.5). All
values were expressed as median and range unless indi-
cated differently. When comparing groups, statistical sig-
nificance was determined by using non-parametric Mann-




The physical characteristics of the animals at the end of
the training period are reported in Table 1. Although TRA
rats were slightly leaner than CTR rats (p = ns), no statisti-
cally significant differences in heart weight, in heart-to-
body weight ratio or in the thickness of the left ventricular
wall were observed. This indicates that training did not
induce cardiac hypertrophy. However, two evidences
showed that animals had been efficiently trained: i) the
soleus to body weight ratio was higher in TRA than in CTR
rats; and, moreover, ii) during the second and the last
week of training each rat was evaluated for maximal
endurance running capacity, which resulted to be in the
15–25 min range while running at 15 m/min in the sec-
ond week and in 100–120 min range at 25 m/min in the
last week.
Affymetrix Gene Expression Profiling of exercise-trained 
and control rats
After data processing and application of the filtering crite-
ria, the average of analyzable probe sets numbered
14,911. The full list of the 300 most expressed genes in the
overall animal population (n = 10 CTR + n = 10 TRA), as
well as the Gene Ontology analysis (for biological process
and molecular function) are available as Additional File 2,
3 and 4. The 300 most expressed genes in LV are involved
in the following biological processes: protein biosynthe-
sis, electron transport, muscle development, regulation of
heart contraction, fatty acid metabolism, ATP synthesis
coupled proton transport, glycolysis, response to oxida-
tive stress, cytoskeleton organization and biogenesis, pro-
tein folding, signal transduction and protein
modification. By using the SAM method to assess the
expression of the 14,911 called transcripts, we observed
12 transcripts (10 genes) differentially expressed in LV
hearts of TRA animals with respect to CTR controls (Table
2). All differentially expressed genes showed an increased
expression in TRA animals with respect to CTR controls.
We focused our attention into three genes that microarray
analysis placed on top of the list on the differentially reg-
Table 1: Animal characteristics.
Control rats Exercise-trained rats p
Number of animals 10 10
Body weight, g 588 (496–629) 567 (519–613) ns
Heart weight, g 1.41 (1.30–1.56) 1.40 (1.23–1.60) ns
Heart/body weight ratio 2.46 (2.27–2.66) 2.48 (2.34–2.80) ns
Left ventricle wall thickness, mm 4.16 (3.70–5.10) 4.08 (3.55–5.02) ns
LV/(RV+S) 0.95 (0.81–1.04) 0.91 (0.84–1.47) ns
Soleus/body weight ratio 0.38 (0.30–0.48) 0.45 (0.40–0.51) 0.002
LV/(RV+S) = Left ventricle/(right ventricle + septum) wall thickness. Data are expressed as median and range.Page 5 of 13
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(RGD1306959), Cav3 and Eno3], and one gene (Hif-
1alpha), which was not found different between TRA and
CTR rats by the microarray analysis. We tested Hif-1 alpha
gene by a further method with a different sensitivity, RT-
PCR, because it may be potentially involved in the modu-
lation of the expression of two up-regulated genes [Eno3
and EGL nine homolog 1 (Egln1)]. Interestingly, one pre-
dicted gene, similar to C11orf17 protein (RGD1306959),
was found to be significantly increased by three different
probe sets, suggesting the potential role of this gene in the
cardioprotective effect of exercise (Table 2).
GSA analysis
In order to identify functional gene sets correlated with
the mild chronic exercise training, we applied GSA analy-
sis. GSA analysis identified 2 gene sets out of 459 whose
expression was correlated with exercise training, namely
ARENRF2PATHWAY (http://www.biocarta.com/path
files/h_ARENRF2PATHWAY.asp; p < 0.0001 and FDR = 0)
and GABAPATHWAY (http://www.biocarta.com/path
files/h_GABAPATHWAY.asp; p < 0.0001 and FDR = 0)
(Table 3).
The ARENRF2PATHWAY (Oxidative Stress Induced Gene
Expression Via Nrf2) is a pathway involved in the oxida-
tive stress through Nrf1 and Nrf2 transcription factors that
bind to antioxidant response elements (AREs) (Table 3).
The GABAPATHWAY (Gamma-aminobutyric Acid Recep-
tor Life Cycle) is a pathway that includes genes involved
in the gamma-aminobutyric acid signaling responsible for
important cellular functions such as synaptic transmis-
sion, ion channel activity, and oxidative stress (Table 3).
Validation analysis by RT-PCR of RGD1306959, Cav3, 
Eno3 and Hif1a gene expression
RT-PCR analysis confirmed the increased expression, pre-
viously observed by GeneChip Affymetrix technology, of
Cav3, Eno3 and RGD1306959 genes in moderately
trained rats with respect to control rats (p = 0.029, p =
0.043, and p = 0.034 respectively) (Figure 1). As concerns
Hif-1 alpha gene expression, the microarray data were
actually confirmed by RT-PCR, since it narrowly failed to
reach the statistical significance (p = 0.052) between CTR
and TRA rats.
Western Blot and Immunohistochemistry analysis of 
caveolin 3
As analyzed by Western Blot, the protein level of caveolin
3 in left ventricles of TRA rats was significantly higher with
respect to CTR rats (p = 0.027) in agreement with the
mRNA expression level (Figure 2).
Table 2: Differentially expressed genes between control (n = 10) and trained (n = 10) rat groups.
Gene Name (Gene Symbol) Gene ID GenBank Probe name D r
similar to C11orf17 protein (RGD1306959) 361624 BF561368 1392938_s_at 5.039 1.5
caveolin 3 (Cav3) 29161 NM_019155 1387814_at 4.216 1.4
similar to RIKEN cDNA 1700012G19 gene (RGD1307773) 287115 BG380656 1388881_at 4.206 1.2
similar to C11orf17 protein (RGD1306959) 361624 AA799992 1385458_a_at 4.168 1.6
enolase 3, beta (Eno3) 25438 NM_012949 1386907_at 4.135 1.5
similar to C11orf17 protein (RGD1306959) 361624 BF561368 1383175_a_at 3.947 1.5
cytochrome P450, family 27, subfamily a, polypeptide 1 (Cyp27a1) 301517 M73231 1387914_at 3.927 1.4
similar to RIKEN cDNA 2700002I20 (RGD1307279) 307210 AI171367 1373074_at 3.783 1.3
EGL nine homolog 1 (Egln1) 308913 BI282122 1389207_at 3.652 1.2
Unknown NA BI295165 1373167_at 3.594 1.2
cystatin C (Cst3) 25307 BG666933 1370855_at 3.457 1.3
tumor necrosis factor, alpha-induced protein 1 (endothelial) (Tnfaip1) 287543 BM390023 1371911_at 3.433 1.2
Probe name = Affymetrix number of the probe set that recognized the specific transcript; d = significance analysis of microarrays (SAM) t-statistic; 
r = fold change according to SAM [mean(TRA intensities)/mean(CTR intensities)].Page 6 of 13
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resulted positive for immuno-staining of the caveolin 3
(Figure 2). A stronger staining (p = 0.0024) was observed
in exercise trained animals with respect to sedentary con-
trols (Figure 2).
Double labeling of cryo-sections from trained rat hearts
with anti-caveolin 3 and anti-myosin heavy chain anti-
bodies showed that the cells displaying intense mem-
brane positivity for caveolin 3 also stained for sarcomeric
myosin, thus indicating that caveolin 3 is increased in car-
diomyocytes (Figure 3).
Ischemia-reperfusion
In order to evaluate the cardioprotective effect of the mild
chronic exercise training protocol, I/R experiments were
performed. Figure 4 summarizes the I/R findings by
reporting a slice of the myocardium from a control (left)
and a trained (right) animal. The red and blue areas rep-
resent, respectively, the area at risk of infarct and the per-
fused area. The mean risk area, expressed as a percentage
of total ventricle area, i.e., the sum unstained plus red-
stained area with respect to total ventricle area, was 39.0%
(± 2.1%) and 38.0% (± 0.8%) in control and trained rats
(p = ns). As these data were essentially the same in the two
groups, one can derive that the severity of left anterior
descending artery (LAD) occlusion was the same. By con-
trast, the white area, that represents the infarct size, when
expressed as a percentage of the risk area, was larger in
control than in trained animals [50.0% (± 3.9%) vs.
37.0% (± 1.1%), p = 0.02], indicating improved myocar-
dial protection in trained animals.
Discussion
In this study, we show that the 10-week mild exercise aer-
obic training (~60% VO2max) induces cardioprotection
to I/R and alters the gene expression profile in rat left ven-
tricles at 48 hours after the last training session. The differ-
entially expressed genes were: Cav3; Eno3; cytochrome
P450, family 27, subfamily a, polypeptide 1 (Cyp27a1);
Egln1; cystatin C (Cst3) and tumor necrosis factor, alpha-
induced protein 1 (endothelial) (Tnfaip1) genes, along
with the two RGD1306959 and RGD1307773 predicted
genes and two unidentified clones. Present data indicate
Table 3: Genes in the ARENRF2PATHWAY (Antioxidant Response Elements Nrf1 and Nrf2 pathway) and GABAPATHWAY 
(Gamma-AminoButyric Acid pathway).
GENE NAME GENE SYMBOL
ARENRF2PATHWAY
http://www.biocarta.com/pathfiles/h_ARENRF2PATHWAY.asp
cAMP responsive element binding protein 1 Creb1
FBJ murine osteosarcoma viral oncogene homolog Fos
FXYD domain-containing ion transport regulator 2 Fxyd2
Jun oncogene Jun
Kelch-like ECH-associated protein 1 Keap1
mitogen activated protein kinase 1 Mapk1
mitogen activated protein kinase 14 Mapk14
nuclear factor, erythroid derived 2, like 2 Nfe2l2
protein kinase C, alpha Prkca
protein kinase C, beta 1 Prkcb1
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G Mafg




gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1 Gabra1
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 Gabra3
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 Gabra4
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 Gabra5
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 Gabra6
gamma-aminobutyric acid receptor associated protein Gabarap
Gephyrin Gphn
N-ethylmaleimide sensitive fusion protein Nsf
Rous sarcoma oncogene Src
ubiquilin 1 Ubqln1Page 7 of 13
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tive, as demonstrated by the higher running capacity and
the soleus to body weight ratio in TRA rats with respect to
CTR rats, without inducing cardiac hypertrophy, as dem-
onstrated by the absence of differences in heart-to-body
weight ratio and in the thickness of the left ventricular
wall between TRA and CTR rats.
The described mild exercise training model determined
development of cardioprotection, as evaluated by I/R
experiments, similarly to what reported in the case of
intense training procedures [29], as demonstrated by the
fact that the infarct size was larger in CTR than in TRA.
These data are coherent with the previous observation
obtained by our group with a similar training protocol
[14].
The selected experimental design satisfies several pur-
poses. First, the applied mild training protocol resembles
that practiced by adult humans for cardiovascular fitness.
Ten-week training duration enabled the onset of cardiac
adaptations and allowed for the estimation of the possible
occurrence of cardiac hypertrophy [9,17,18]. Second, rats
were sacrificed 48 hours after the last training session in
order to rule out acute effects of exercise and to evaluate
gene expression changes due to chronic adaptation. It
might be hypothesized that the cardioprotection resulting
from the adaptation to mild chronic exercise training is
the result of a summation of several second windows of
protection similar to what observed during ischemic pre-
conditioning. In fact, transient ischemic events may occur
during exercise at high heart rate, when the time available
for diastolic coronary flow is reduced and myocardial con-
tractility as well as mechanical compression is likely to
impede coronary flow [30]. Moreover, the experimental
design allowed us to compare and extend on a larger
number of genes data reported in a previous paper [14]
employing a similar chronic mild training protocol.
Gene expression profile changes induced by exercise train-
ing have been investigated in previous studies that
employed training procedures of a more intense nature
than those used in this study and that, in contrast to the
protocol of this study, induced cardiac hypertrophy
[9,17,18]. Differentially expressed genes reported in those
studies differ highly in number and type, not only when
compared to those reported in the present work, but also
when a comparison is drawn among them. Conflicting
results may stem from the intensity, duration of protocols,
and distance of the sacrifice from the last exercise bout.
However, it is interesting to note that in the studies cited
above the number of differentially expressed genes
decreased according to the time that elapsed from the last
exercise bout to the sacrifice, suggesting a restoring of gene
expression to levels comparable to those of sedentary con-
trol animals: 24 hours (305 genes) [9], 48 hours (75
genes) [17], 72 hours (27 genes) [18].
Recently, Freimann and coworkers [11,31] evaluated gene
expression profiles of heart from rats which received a 7-
week swimming exercise training and underwent surgi-
cally-induced myocardial infarction. The gene expression
profiles were evaluated before, 4 hours, 2 days and 4
weeks after surgery. Differentially expressed genes did not
overlap, at any time point, with those reported here. How-
ever, the experimental design of the Freimann's group dif-
fered from ours as we evaluated the gene expression
profiles that characterized animals after the mild chronic
exercise and, in a different set of rats trained in parallel
using an identical training protocol, we determined the
cardioprotection by measuring the extent of the injury
caused by ischemia/reperfusion experiments. Concerning
the previous paper of our group [14], none of the 14 dif-
ferentially expressed genes identified (96 candidate genes
Gene expression analysis by real time RT-PCR of similar to C11orf17 protein (RGD1306959), caveolin 3, enolase 3 and Hif-1 alpha gen s i  trained and control ratsFigur  1
Gene expression analysis by real time RT-PCR of 
similar to C11orf17 protein (RGD1306959), caveolin 
3, enolase 3 and Hif-1 alpha genes in trained and con-
trol rats. Data are expressed as mean ± SE; p-values are 
referred to trained vs. control rats.Page 8 of 13
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genes found differentially expressed in the present study.
On the other hand, two different technologies – a mac-
roarray focused on 96 genes in the previous paper and
Affymetrix GeneChips representing 31.000 transcripts in
the present paper – were used.
Among the differentially expressed transcripts, we pointed
our attention on 3 genes: similar to C11orf17 protein
(RGD1306959), Eno3 and Cav3.
The predicted sequence of similar to C11orf17 protein
(RGD1306959) has a high homology (mRNA nucleotide:
90%–92%; protein: 77% on positivity) with the human
C11orf17 [alias: protein kinase-A interacting protein 1
(AKIP1) or breast cancer associated gene 3 (BCA3)].
C11orf17 has been recently shown to enhance NF-κB-
mediated gene expression [32], a redox-sensitive tran-
scription factor, known to be involved in the control of a
large number of cellular processes, such as immune and
inflammatory responses, developmental processes, cellu-
lar growth, and apoptosis. The gene expression of similar
to C11orf17 protein (RGD1306959) gene was found
increased in LV of hypertensive rats and positively corre-
lated with LV mass index, thus pointing to its potential
implication in LV hypertrophy development [33]. Inter-
estingly, in these hypertensive rats, Eno3 showed a nega-
tive correlation with LV mass index [33], whereas, in our
model of mild physical exercise without cardiac hypertro-
phy, Eno3 gene showed an increased expression in trained
rats. Our findings, together with data obtained in hyper-
tensive rat models, strongly suggest a relevant role of sim-
ilar to C11orf17 protein (RGD1306959) gene in the
adaptive response of the cardiac muscle mass to the work-
load; this mechanism could be balanced by the up-regula-
tion of the Eno3 gene. Eno3 gene encodes one of the three
Immunohistochemistry and western blot quantification of caveolin-3Figure 2
Immunohistochemistry and western blot quantification of caveolin-3. Top: Left ventricle slides were obtained from 
frozen tissue by a cryotome and stained with anti caveolin-3 antibody, followed by HRP-conjugated secondary antibody and 
DAB reaction. One representative picture of cardiac tissue from controls and trained rats is shown. Immunohistochemistry 
images were analyzed by a software, which allowed the evaluation of the percentage of the area that reacted with anti caveolin-
3 antibody. P-values are referred to trained vs. control rats. Bottom: Representative Western Blot assay with anti caveolin-3 
antibodies. Bands of approximately 18 kDa correspond to caveolin 3 monomer. Cytoplasmic actin (43 kDa) was immunos-
tained for equal loading control in the same gel. Lanes 1 to 4: protein extracted from left ventricle of control rats. M: markers. 
Lanes 5 to 8: protein extracted from left ventricle of exercise trained rats. The Western Blot was scanned by a densitometer 
and caveolin-3/actin ratio was found significantly larger in blots from trained rat hearts respect to controls.Page 9 of 13
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is found in skeletal and cardiac muscle cells. The func-
tional role of this gene in heart muscle, as well as skeletal
muscles, has not been elucidated yet. Several reports
described a role for the hypoxia-inducible factor-1 (HIF-
1) in the transcriptional activation of enolase-1 [34], and
enolase-2 genes [35]. In the present study, Hif-1alpha
showed a trend toward increased expression in trained
rats, thus suggesting that Hif-1alpha could be regulated
also by non-hypoxic stimuli. In a recent proteomics study,
enolase 1 alpha and proteins similar to alpha enolase
have been found to increase in exercised rats [36]. Moreo-
ver, beta enolase was observed to increase in athletes after
running a race [37]. These data further indicate an impor-
tant role of beta enolase in the preconditioning phenom-
ena that induce cardioprotection.
Using the present protocol of mild exercise training an
increased expression of caveolin 3 at transcriptomic and
proteomic levels was demonstrated. In cardiomyocytes,
caveolin 3 is a major constituent of caveolae, plasma
membrane invaginations implicated in vesicular traffick-
ing, signal transduction, and Ca2+ homeostasis [38]. The
influence of caveolin 3 on hypertrophy has been previ-
ously suggested by a number of evidences, including the
development of cardiac hypertrophy in caveolin 3-null
mice [39], the inhibition of agonist-induced cardiomyo-
cyte hypertrophy by overexpression of caveolin 3 [40],
and the observation that exercise training, preventing
pathological hypertrophy in spontaneously hypertensive
rats, is associated to the overexpression of caveolin 3 [41].
Moreover, it has been found that caveolin 3 induces pro-
tection of cardiac myocytes from ischemic damage [42].
All these results lend support to the hypothesis that exer-
cise training-induced cardioprotection to I/R is not only
accompanied by the overexpression of caveolin 3, but also
strictly related to it by a cause-effect relationship.
In order to identify functional gene sets correlated with
mild chronic exercise training, we applied GSA analysis.
GSA analysis identified only 2 gene sets correlated with
exercise training: the ARENRF2PATHWAY and the GABA-
PATHWAY. There are some evidences that physical exer-
cise leads to the enhanced transient formation of reactive
oxygen species (ROS) [14]. Oxygen radicals are important
intracellular second messengers that mediate cardiopro-
tection [43]. Increased levels of ROS generated in working
muscles favor a change in the redox-balance towards a
more pro-oxidant state counteracted by a complex net-
work of antioxidant systems [44], as suggested by the
association of exercise with the "Oxidative stress induced
gene expression via Nrf2" pathway. The functional conse-
quences of exercise-induced oxidative stress are only
partly understood; nevertheless, the present data demon-
strated that our protocol is able to induce cardioprotec-
tion, as evaluated by functional I/R experiments. In
addition, the association of the GABA pathway with train-
ing is consistent with the role of GABA receptor activity in
the cardioprotection induced by ischemic precondition-
ing [43]. The association of these two pathways is consist-
ent with our data on Cav3 upregulation: in fact, several
data showed that caveolin 3 protein plays an important
role in ROS response through MAP kinases mediated
intracellular signal transduction underlying cardioprotec-
tion [45,46].
Even if we confirmed by other molecular biology
approaches the coherence of our microarray data, this
study have the limitations of all transcriptomics
approaches concerning the post-transcriptional and post-
transductional behavior of the differentially expressed
genes and the possibility of type I (false positive genes)
and type II (false negative genes) statistical error due to
the high number of parameters investigated in each exper-
iments.
Conclusion
In conclusion, mild aerobic chronic exercise training, at a
level that does not induce cardiac hypertrophy, was found
to induce cardioprotection toward I/R events. Even if our
results underline the finding that gene expression profiles
of left ventricles from sedentary and trained rats were very
similar, in spite of the persistence of exercise-induced car-
dioprotection, the fact that few genes appear to be overex-
pressed in LV of trained animals suggests that they may be
Fluorescence microscopy view of a longitudinal section of cardiomyo ytes fr m a trained rat heart, double labeled with anti-cave lin 3 antibody (gre n) – stai ing the ce l mem-branes – and anti-myosin h avy ch in (re ) – staining the sar-om rigure 3
Fluorescence microscopy view of a longitudinal sec-
tion of cardiomyocytes from a trained rat heart, dou-
ble labeled with anti-caveolin 3 antibody (green) – 
staining the cell membranes – and anti-myosin heavy 
chain (red) – staining the sarcomers. Nuclei have been 
counter labeled in blue. Magnification: 400×.Page 10 of 13
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While further global transcriptomic and proteomic profil-
ing, carried out during and at different times after bout of
exercise, may help to better understand the molecular
mechanisms underlying the beneficial effect of mild exer-
cise training, the present results clearly show a link
between the long lasting expression of some exercise
training-induced genes and cardioprotection.
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